Publication | Closed Access

Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy

Hematological MalignancyAll-trans-retinoic AcidOncologyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyMyeloid NeoplasiaArsenic TrioxideAdult T-cell Leukemia-lymphomaPharmacologyRadiation OncologyAcute Promyelocytic LeukemiaCancer ResearchHealth Sciences